Cells with higher expression of a housekeeping gene have a decreased expression of viral genes. by Efrat M. Cohen (3384470)

Changes in the normalized volume <i>v</i> = V/V₀ of HEK293 cells in response to sequential application of sucrose and <i>myo</i>-inositol solutions of the same osmolalit... by Joseph Andronic (700242)

“…<p>The cells were bathed initially (<i>time</i> < ∼30 s) in isotonic growth medium (300 mOsm) and then exposed to a 100-mOsm sucrose solution. The strongly hypotonic sucrose solution (<i>filled symbols</i>) caused fast cell swelling to a transient maximum volume <i>v</i>_max of ∼1.6 within the first 2–3 min. …”

Decreased nephrin expression. by Sandra Müller-Krebs (485766)

Whole brain FC matrix (comprising of 100 ROI) defined based on Pearson’s correlation. by Ishita Rai Bansal (13162713)

Fast Electrochemical Netting of Composite Chains for Transferable Highly Conductive Polymeric Nanofilms by Bingxi Yan (1667488)

“…However, high conductivity of existing CP films vanishes as thickness decreases to the nanoscale (i.e., below 100 nm), with an unclear mechanism so far. …”

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

Histopathological examination of MSCs and short-term cyclosporine A (CsA) decreases allotransplant rejection. by Yur-Ren Kuo (325023)

Predicted steady state distribution of the percent of TDLs in a 1) control animal, 2) following increased in the average residence time of lymphocytes in the lung (20 fold, from 26... by Vitaly V. Ganusov (142019)

A genetic variant in human FIRE is associated with a decreased interferon response in myeloid cells. by Anaïs Assouvie (9600529)

ATRA treatment induces expression of S100 and inhibits PMP22 expression. by Susan Fischer-Huchzermeyer (4588522)

“…Bars indicate increase or decrease of fluorescence intensity (%) compared to untreated controls (100%). …”

Identification of the 12T-ins/del polymorphism in the <i>ATP1A1</i> promoter region and transcriptional activity of <i>ATP1A1</i> promoter variants. by Victoria L. Herrera (383897)

Activator A10 increases and inhibitor G8 decreases the rate of PMA-induced PKCε-EGFP translocation in HeLa cells. by Milla Summanen (325769)

Oxytocin decreases locally evoked CeA GABAergic signaling and blunts alcohol effects. by Brendan J. Tunstall (6593357)

“…(B) Effect of 3 concentrations of oxytocin (100, 500, and 1,000 nM) on eIPSP amplitudes in CeA neurons from alcohol-nondependent and -dependent rats. …”

a. Mixed Linear Effects modeling results (GLMM, using a logit link function) for 28 d survival. by April S. Cameron (8622711)

Replication Validity of Initial Association Studies: A Comparison between Psychiatry, Neurology and Four Somatic Diseases by Estelle Dumas-Mallet (2851265)

“…Among the 256 initial studies reporting a significant effect (p<0.05) and paired with significant meta-analyses, 97 effect sizes were inflated by more than 100%. …”

Data Sheet 1_Impact of atopic dermatitis on renal dysfunction: insights from patient data and animal models.pdf by Arisa Ikeda (20912510)

“…In addition, the gene expression of slit diaphragm- and podocyte-related proteins such as nephrin, podocin, and synaptopodin decreased, whereas the gene expression of inflammatory mediators such as S100A8 and S100A9 increased.…”

TLR2 siRNA treatment decreases TLR2 gene expression in uninfected and <i>M. abscessus</i> -infected A549 cells. by Lisa B. Davidson (336990)

“…<p>As a first step in assessing the role of TLR2 in respiratory epithelial responses to <i>M. abscessus</i>, the effect of transfection of A549 cells with TLR2 siRNA on TLR2 gene expression was assessed. …”

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)